Lista de obras - Mario Mondelli - Dominio Público Uruguay

A Human Monoclonal Antibody against Hepatitis B Surface Antigen with Potent Neutralizing Activity

artículo científico publicado en 2015

A human antibody specific for hepatitis C virus core protein: synthesis in a bacterial system and characterization.

artículo científico publicado en 1995

A human monoclonal antibody specific for the N terminus of the hepatitis C virus nucleocapsid protein.

artículo científico publicado en 1993

A survey of hepatitis C virus infection in haemodialysis patients over a 7-year follow-up ⬇️

artículo científico publicado el 1 de octubre de 1997

Abnormal Alanine Aminotransferase Activity Reflects Exposure to Hepatitis C Virus in Haemodialysis Patients ⬇️

artículo científico publicado el 1 de enero de 1991

Absence of antibodies to HIV in long term institutionalized psychiatric patients

scientific article published on 01 June 1989

Acute hepatitis C: diagnosis and management.

artículo científico publicado en 2004

Alpha-interferon enhances non-T cell cytotoxicity for autologous hepatocytes in acute and chronic HBV infection

scientific article published on 01 January 1986

Altered natural killer cell cytokine profile in type 2 autoimmune hepatitis.

artículo científico publicado en 2017

An Anti-MICA/B Antibody and IL-15 Rescue Altered NKG2D-Dependent NK Cell Responses in Hepatocellular Carcinoma

scientific article published on 30 November 2020

Analysis of Hepatitis C Virus Hypervariable Region 1 Sequence from Cryoglobulinemic Patients and Associated Controls

artículo científico publicado en 2007

Antibody-negative chronic hepatitis C virus infection in immunocompetent children ⬇️

artículo científico publicado el 1 de junio de 1998

Assessment of hepatitis C virus-RNA clearance under combination therapy for hepatitis C virus genotype 1: performance of the transcription-mediated amplification assay.

artículo científico publicado en 2008

Association between HLA class II alleles and protection from or susceptibility to chronic hepatitis C.

artículo científico publicado en 1998

Baseline and Breakthrough Resistance Mutations in HCV Patients Failing DAAs

artículo científico publicado en 2017

Chloroquine enhances human CD8+ T cell responses against soluble antigens in vivo

artículo científico publicado en 2005

Clonality and specificity of cryoglobulins associated with HCV: pathophysiological implications

artículo científico publicado en 1998

Codon 72 polymorphism of P53 gene does not affect the risk of cirrhosis and hepatocarcinoma in HCV-infected patients.

artículo científico publicado en 2004

Critical reappraisal of risk factors for occurrence of hepatocellular carcinoma in patients with hepatitis C virus.

artículo científico publicado en 2011

Cyclosporin for Crohn's disease

artículo científico publicado en 1984

Decreased interferon-γ production by NK cells from KIR haplotype B carriers in hepatitis C virus infection

scientific article published on 26 June 2019

Deficient Natural Killer Cell NKp30-Mediated Function and Altered NCR3 Splice Variants in Hepatocellular Carcinoma

scientific article published on 14 February 2019

Definition of hepatitis B virus (HBV)-specific target antigens recognized by cytotoxic T cells in acute HBV infection.

artículo científico publicado en 1987

Detection of HTLV-III-specific IgG bands in the CSF from a patient with AIDS and encephalitis.

artículo científico publicado en 1988

Detection of genomic- and minus-strand of hepatitis C virus RNA in the liver of chronic hepatitis C patients by strand-specific semiquantitative reverse-transcriptase polymerase chain reaction.

artículo científico publicado en 1999

Differences in the availability of diagnostics and treatment modalities for chronic hepatitis B across Europe

artículo científico publicado en 2015

Different combinations of cytokines and activating receptor stimuli are required for human natural killer cell functional diversity.

artículo científico publicado en 2013

Direct-Acting Antivirals Cure Innate Immunity in Chronic Hepatitis C.

artículo científico publicado en 2015

Dissociation of serum and liver hepatitis C virus RNA levels in patients coinfected with human immunodeficiency virus and treated with antiretroviral drugs

artículo científico publicado en 2004

Do Liver Mucosa-Associated Invariant T Cells Delay Hepatitis C Progression, or Are They Innocent Bystanders?

artículo científico publicado en 2017

Dynamics of hypervariable region 1 variation in hepatitis C virus infection and correlation with clinical and virological features of liver disease.

artículo científico publicado en 1998

Editor's Note

Efficacy of low-dose rituximab for the treatment of mixed cryoglobulinemia vasculitis: Phase II clinical trial and systematic review

artículo científico

Eltrombopag: an effective remedy for thrombocytopaenia?

artículo científico publicado en 2008

Engagement of Siglec-7 receptor induces a pro-inflammatory response selectively in monocytes

artículo científico publicado en 2012

Enhanced B-cell differentiation and reduced proliferative capacity in chronic hepatitis C and chronic hepatitis B virus infections.

artículo científico publicado en 2010

Exosomes: multitask cargo carriers modulating innate immunity to viruses.

artículo científico publicado en 2016

Expansion of atypical memory B cells is a prominent feature of COVID-19

artículo científico publicado en 2020

Functional characterization of peripheral blood lymphocytes in chronic HBsAg carriers

scientific article published on 01 March 1986

Functional modulation of hepatitis B core antigen-specific T lymphocytes by an autoreactive T cell clone

artículo científico publicado en 1988

Genetic polymorphisms of steroid hormone metabolizing enzymes and risk of liver cancer in hepatitis C-infected patients.

artículo científico publicado en 2003

HCV E1E2-MF59 vaccine in chronic hepatitis C patients treated with PEG-IFNα2a and Ribavirin: a randomized controlled trial

artículo científico publicado en 2013

HCV intergenotype 2k/1b recombinant detected in a DAA-treated patient in Italy.

artículo científico publicado en 2017

HGV/GBV-C infection in liver transplant recipients: antibodies to the viral E2 envelope glycoprotein protect from de novo infection.

artículo científico publicado en 1998

Hepatitis C virus genotype 1b as a major risk factor associated with hepatocellular carcinoma in patients with cirrhosis: a seventeen-year prospective cohort study

artículo científico publicado en 2007

Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: a meta-analysis

artículo científico publicado en 2009

Hepatitis C virus genotypes and risk of cirrhosis in southern Italy.

artículo científico publicado en 2001

Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a case-control study.

artículo científico publicado en 1996

Hepatitis C virus infection among institutionalised psychiatric patients: a regression analysis of indicators of risk.

artículo científico publicado en 1997

Hepatitis C virus inhibits CD4 T cell function via binding to Toll-like receptor 7.

artículo científico publicado en 2016

Hepatitis C virus-induced NK cell activation causes metzincin-mediated CD16 cleavage and impaired antibody-dependent cytotoxicity

artículo científico publicado en 2017

Hepatitis C: Is eradication possible?

scientific article published on 10 January 2019

High efficiency of vertical transmission of hepatitis C virus among babies born to human immunodeficiency virus-negative women.

artículo científico publicado en 1995

High prevalence of antibodies to hepatitis C virus in hemodialysis units using a second generation assay

artículo científico publicado el 1 de enero de 1992

Human Monoclonal Antibodies as Adjuvant Treatment of Chronic Hepatitis B Virus Infection

artículo científico publicado en 2019

Hypervariable region 1 of hepatitis C virus: immunological decoy or biologically relevant domain?

artículo científico publicado en 2001

ITPA and SLC29A1 Genotyping for the Prediction of Ribavirin Dose Reduction in Anti-HCV Triple Therapy with Protease Inhibitors.

artículo científico publicado en 2015

Identification of HCV Core Mimotopes: Improved Methods for the Selection and Use of Disease-Related Phage-Displayed Peptides ⬇️

artículo científico publicado el 1 de junio de 1997

Immunoglobulin on the surface of isolated hepatocytes is associated with antibody-dependent cell-mediated cytotoxicity and liver damage

artículo científico publicado en 1987

Immunopathological mechanisms of liver cell injury in chronic hepatitis B virus infection.

artículo científico publicado en 1986

In vitro effect of lymphoblastoid alpha-interferon on subpopulations of effector cells mediating cytotoxicity for autologous hepatocytes in hepatitis B and non-A, non-B

scientific article published on 01 January 1986

Induction of cross-reactive humoral immune response by immunization with mimotopes of the hypervariable region 1 of the hepatitis C virus.

artículo científico publicado en 2001

Insulin resistance is associated with liver fibrosis in non-diabetic chronic hepatitis C patients

artículo científico publicado en 2005

Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C.

artículo científico publicado en 2006

Is response to antiviral treatment influenced by hepatitis B virus genotype?

scientific article published on 06 January 2010

Is the natural history of hepatitis C virus carriers with normal aminotransferase really benign? ⬇️

artículo científico publicado el 1 de diciembre de 2001

Kinetics and significance of serum hepatitis C virus core antigen in patients with acute hepatitis C

artículo científico publicado en 2003

Lack of Siglec-7 expression identifies a dysfunctional natural killer cell subset associated with liver inflammation and fibrosis in chronic HCV infection.

artículo científico publicado en 2015

Liver international - between tradition and innovation

artículo científico publicado en 2014

Lymphocyte cytotoxicity for autologous hepatocytes.

artículo científico publicado en 1984

Lymphocyte cytotoxicity to autologous hepatocytes in alpha 1-antitrypsin deficiency ⬇️

artículo científico publicado el 1 de octubre de 1984

Management of infections in cirrhotic patients: report of a consensus conference

artículo científico publicado en 2013

Management of infections pre- and post-liver transplantation: report of an AISF consensus conference

artículo científico publicado en 2013

Management of liver diseases 2008. Foreword

artículo científico publicado en 2008

Mechanisms of liver cell injury in acute and chronic hepatitis B

scientific article published on 01 February 1984

Mimotopes of the hyper variable region 1 of the hepatitis C virus induce cross-reactive antibodies directed against discontinuous epitopes.

artículo científico publicado en 2001

Molecular epidemiology of hepatitis C virus infection among intravenous drug users.

artículo científico publicado en 1995

Monitoring Response to Antiviral Therapy for Patients with Chronic Hepatitis C Virus Infection by a Core-Antigen Assay

artículo científico publicado en 2003

Monitoring response to antiviral treatment by serum hepatitis C virus core antigen: too early to take shortcuts?

artículo científico publicado en 2004

Monocytes inhibit hepatitis C virus-induced TRAIL expression on CD56bright NK cells

artículo científico publicado en 2017

Multispecific T cell response and negative HCV RNA tests during acute HCV infection are early prognostic factors of spontaneous clearance

artículo científico publicado en 2004

NKG2D and its ligands: Key to immunotherapy of liver cancer? ⬇️

artículo científico publicado el 26 de julio de 2011

NKp30 isoforms in patients with chronic hepatitis C virus infection

artículo científico publicado en 2015

Natural Killer Cell Responses in Hepatocellular Carcinoma: Implications for Novel Immunotherapeutic Approaches

scientific article published on 09 April 2020

Natural killer activity in patients with acute viral hepatitis

scientific article published on 01 April 1986

Natural killer cell dynamic profile is associated with treatment outcome in patients with chronic HCV infection

artículo científico publicado en 2013

Natural killer cells in viral hepatitis: facts and controversies.

artículo científico publicado en 2010

New treatment options in chronic hepatitis B

artículo científico publicado en 2008

Occult hepatitis B virus infection.

artículo científico publicado en 2000

PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV.

artículo científico publicado en 2009

Performance of Real-Time Strain Elastography, Transient Elastography, and Aspartate-to-Platelet Ratio Index in the Assessment of Fibrosis in Chronic Hepatitis C

scientific article published on 01 July 2012

Performance of liver stiffness measurements by transient elastography in chronic hepatitis.

artículo científico publicado en 2013

Peripheral blood lymphocyte subpopulations after splenectomy for trauma

scientific article published on 01 January 1987

Properties of a human monoclonal antibody specific for the NS4 region of hepatitis C virus ⬇️

artículo científico publicado el 1 de junio de 1993

Prospective study of natural killer cell phenotype in recurrent hepatitis C virus infection following liver transplantation.

artículo científico publicado en 2008

RE: Effects of Long-Term Norfloxacin Therapy in Patients With Advanced Cirrhosis

artículo científico publicado en 2019

Recombinant human antibodies specific for hepatitis C virus proteins ⬇️

artículo científico publicado el 1 de enero de 1997

Relationship between expression of hepatitis B virus antigens in isolated hepatocytes and autologous lymphocyte cytotoxicity in patients with chronic hepatitis B virus infection.

artículo científico publicado en 1984

Reply to: “Flow cytometry makes all the difference” ⬇️

artículo científico publicado el 22 de junio de 2013

Review article: immune checkpoint inhibitors and the liver, from therapeutic efficacy to side effects

artículo científico publicado en 2019

Role of humoral immune responses in hepatitis B and C virus infections.

artículo científico publicado en 1995

Sialic acid-binding Ig-like lectin-7 interacts with HIV-1 gp120 and facilitates infection of CD4pos T cells and macrophages

scientific article published on 13 December 2013

Significance of the immune response to a major, conformational B-cell epitope on the hepatitis C virus NS3 region defined by a human monoclonal antibody

artículo científico publicado en 1994

Skewed B cells in chronic hepatitis C virus infection maintain their ability to respond to virus-induced activation

artículo científico publicado en 2014

Statements from the Taormina expert meeting on occult hepatitis B virus infection

artículo científico publicado en 2008

Subversion of effector CD8+ T cell differentiation in acute hepatitis C virus infection: the role of the virus.

artículo científico publicado en 2004

The Emerging Picture of Hepatitis C ⬇️

artículo científico publicado el 1 de enero de 1991

The impact of hepatitis C virus outside the liver: Evidence from Asia.

artículo científico publicado en 2016

The multifaceted functions of ribavirin: antiviral, immunomodulator, or both?

artículo científico publicado en 2014

The success of HCV cure: every rose has its thorn.

artículo científico publicado en 2017

Towards a solution for hepatitis C virus hypervariability: mimotopes of the hypervariable region 1can induce antibodies cross-reacting with a large number of viral variants ⬇️

artículo científico publicado el 1 de julio de 1998

Unique immunological profile in patients with COVID-19

artículo científico publicado en 2020

Variability or conservation of hepatitis C virus hypervariable region 1? Implications for immune responses ⬇️

artículo científico publicado el 1 de abril de 2003

Vertical transmission of hepatitis C virus and HIV.

artículo científico publicado en 1993

Viral and host immune regulatory mechanisms in hepatitis C virus infection.

artículo científico publicado en 2006

[Direct immune response against hepatic antigens in patients with alpha-1-antitrypsin deficiency]

scientific article published on 01 January 1986

[Trials and prospectives in the treatment of AIDS]

artículo científico publicado en 1986

Lista de obras de Mario Mondelli

A Human Monoclonal Antibody against Hepatitis B Surface Antigen with Potent Neutralizing Activity

A human antibody specific for hepatitis C virus core protein: synthesis in a bacterial system and characterization.

A human monoclonal antibody specific for the N terminus of the hepatitis C virus nucleocapsid protein.

A survey of hepatitis C virus infection in haemodialysis patients over a 7-year follow-up ⬇️

Abnormal Alanine Aminotransferase Activity Reflects Exposure to Hepatitis C Virus in Haemodialysis Patients ⬇️

Absence of antibodies to HIV in long term institutionalized psychiatric patients

Acute hepatitis C: diagnosis and management.

Alpha-interferon enhances non-T cell cytotoxicity for autologous hepatocytes in acute and chronic HBV infection

Altered natural killer cell cytokine profile in type 2 autoimmune hepatitis.

An Anti-MICA/B Antibody and IL-15 Rescue Altered NKG2D-Dependent NK Cell Responses in Hepatocellular Carcinoma

Analysis of Hepatitis C Virus Hypervariable Region 1 Sequence from Cryoglobulinemic Patients and Associated Controls

Antibody-negative chronic hepatitis C virus infection in immunocompetent children ⬇️

Assessment of hepatitis C virus-RNA clearance under combination therapy for hepatitis C virus genotype 1: performance of the transcription-mediated amplification assay.

Association between HLA class II alleles and protection from or susceptibility to chronic hepatitis C.

Baseline and Breakthrough Resistance Mutations in HCV Patients Failing DAAs

Chloroquine enhances human CD8+ T cell responses against soluble antigens in vivo

Clonality and specificity of cryoglobulins associated with HCV: pathophysiological implications

Codon 72 polymorphism of P53 gene does not affect the risk of cirrhosis and hepatocarcinoma in HCV-infected patients.

Critical reappraisal of risk factors for occurrence of hepatocellular carcinoma in patients with hepatitis C virus.

Cyclosporin for Crohn's disease

Decreased interferon-γ production by NK cells from KIR haplotype B carriers in hepatitis C virus infection

Deficient Natural Killer Cell NKp30-Mediated Function and Altered NCR3 Splice Variants in Hepatocellular Carcinoma

Definition of hepatitis B virus (HBV)-specific target antigens recognized by cytotoxic T cells in acute HBV infection.

Detection of HTLV-III-specific IgG bands in the CSF from a patient with AIDS and encephalitis.

Detection of genomic- and minus-strand of hepatitis C virus RNA in the liver of chronic hepatitis C patients by strand-specific semiquantitative reverse-transcriptase polymerase chain reaction.

Differences in the availability of diagnostics and treatment modalities for chronic hepatitis B across Europe

Different combinations of cytokines and activating receptor stimuli are required for human natural killer cell functional diversity.

Direct-Acting Antivirals Cure Innate Immunity in Chronic Hepatitis C.

Dissociation of serum and liver hepatitis C virus RNA levels in patients coinfected with human immunodeficiency virus and treated with antiretroviral drugs

Do Liver Mucosa-Associated Invariant T Cells Delay Hepatitis C Progression, or Are They Innocent Bystanders?

Dynamics of hypervariable region 1 variation in hepatitis C virus infection and correlation with clinical and virological features of liver disease.

Editor's Note

Efficacy of low-dose rituximab for the treatment of mixed cryoglobulinemia vasculitis: Phase II clinical trial and systematic review

Eltrombopag: an effective remedy for thrombocytopaenia?

Engagement of Siglec-7 receptor induces a pro-inflammatory response selectively in monocytes

Enhanced B-cell differentiation and reduced proliferative capacity in chronic hepatitis C and chronic hepatitis B virus infections.

Exosomes: multitask cargo carriers modulating innate immunity to viruses.

Expansion of atypical memory B cells is a prominent feature of COVID-19

Functional characterization of peripheral blood lymphocytes in chronic HBsAg carriers

Functional modulation of hepatitis B core antigen-specific T lymphocytes by an autoreactive T cell clone

Genetic polymorphisms of steroid hormone metabolizing enzymes and risk of liver cancer in hepatitis C-infected patients.

HCV E1E2-MF59 vaccine in chronic hepatitis C patients treated with PEG-IFNα2a and Ribavirin: a randomized controlled trial

HCV intergenotype 2k/1b recombinant detected in a DAA-treated patient in Italy.

HGV/GBV-C infection in liver transplant recipients: antibodies to the viral E2 envelope glycoprotein protect from de novo infection.

Hepatitis C virus genotype 1b as a major risk factor associated with hepatocellular carcinoma in patients with cirrhosis: a seventeen-year prospective cohort study

Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: a meta-analysis

Hepatitis C virus genotypes and risk of cirrhosis in southern Italy.

Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a case-control study.

Hepatitis C virus infection among institutionalised psychiatric patients: a regression analysis of indicators of risk.

Hepatitis C virus inhibits CD4 T cell function via binding to Toll-like receptor 7.

Hepatitis C virus-induced NK cell activation causes metzincin-mediated CD16 cleavage and impaired antibody-dependent cytotoxicity

Hepatitis C: Is eradication possible?

High efficiency of vertical transmission of hepatitis C virus among babies born to human immunodeficiency virus-negative women.

High prevalence of antibodies to hepatitis C virus in hemodialysis units using a second generation assay

Human Monoclonal Antibodies as Adjuvant Treatment of Chronic Hepatitis B Virus Infection

Hypervariable region 1 of hepatitis C virus: immunological decoy or biologically relevant domain?

ITPA and SLC29A1 Genotyping for the Prediction of Ribavirin Dose Reduction in Anti-HCV Triple Therapy with Protease Inhibitors.

Identification of HCV Core Mimotopes: Improved Methods for the Selection and Use of Disease-Related Phage-Displayed Peptides ⬇️

Immunoglobulin on the surface of isolated hepatocytes is associated with antibody-dependent cell-mediated cytotoxicity and liver damage

Immunopathological mechanisms of liver cell injury in chronic hepatitis B virus infection.

In vitro effect of lymphoblastoid alpha-interferon on subpopulations of effector cells mediating cytotoxicity for autologous hepatocytes in hepatitis B and non-A, non-B

Induction of cross-reactive humoral immune response by immunization with mimotopes of the hypervariable region 1 of the hepatitis C virus.

Insulin resistance is associated with liver fibrosis in non-diabetic chronic hepatitis C patients

Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C.

Is response to antiviral treatment influenced by hepatitis B virus genotype?

Is the natural history of hepatitis C virus carriers with normal aminotransferase really benign? ⬇️

Kinetics and significance of serum hepatitis C virus core antigen in patients with acute hepatitis C

Lack of Siglec-7 expression identifies a dysfunctional natural killer cell subset associated with liver inflammation and fibrosis in chronic HCV infection.

Liver international - between tradition and innovation

Lymphocyte cytotoxicity for autologous hepatocytes.

Lymphocyte cytotoxicity to autologous hepatocytes in alpha 1-antitrypsin deficiency ⬇️

Management of infections in cirrhotic patients: report of a consensus conference

Management of infections pre- and post-liver transplantation: report of an AISF consensus conference

Management of liver diseases 2008. Foreword

Mechanisms of liver cell injury in acute and chronic hepatitis B

Mimotopes of the hyper variable region 1 of the hepatitis C virus induce cross-reactive antibodies directed against discontinuous epitopes.

Molecular epidemiology of hepatitis C virus infection among intravenous drug users.

Monitoring Response to Antiviral Therapy for Patients with Chronic Hepatitis C Virus Infection by a Core-Antigen Assay

Monitoring response to antiviral treatment by serum hepatitis C virus core antigen: too early to take shortcuts?